Dual function inhibitors targeting phospholipase A(2) (<< PLA(2) >>) and leukotriene A(4) hydrolase (LTA(4)H) may balance the [[ arachidonic acid ]] (AA) metabolic network and be used as new anti-inflammatory drugs.